
Sangamo Therapeutics SGMO
Quartalsbericht 2026-Q1
hinzugefügt 14.05.2026
Sangamo Therapeutics ROCE 2011-2026 | SGMO
ROCE Jährlich Sangamo Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 849.73 | -456.61 | -330.58 | -68.24 | -48.85 | -16.3 | -18.53 | -15.07 | -23.3 | -50.18 | -23.77 | -11.94 | -20.39 | -30.1 | -44.7 | -44.6 | -27.03 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 849.73 | -456.61 | -22.38 |
ROCE Vierteljährlich Sangamo Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1095.95 | -1237.32 | -824.37 | -824.17 | -299.12 | -379.17 | -217.26 | -144.14 | -79.64 | -40.28 | -45.66 | -57.58 | -50.76 | -46.24 | -32.71 | -33.45 | -29.13 | -27.13 | -17.29 | -24.05 | -31.05 | -33.59 | -24.66 | -29.09 | -27.55 | -25.53 | -15.38 | -22.32 | -24.68 | -28.4 | -22.67 | -36.77 | -49.54 | -54.99 | -46.06 | -52.65 | -44.93 | -28.45 | -16.2 | -19.91 | -16.73 | -14.03 | -10.8 | -15.86 | -16.65 | -18.91 | -15.23 | -24.17 | -27.96 | -34.69 | -29.01 | -40.96 | -44.85 | -47.98 | -36.76 | -11.95 | -12.83 | -11.98 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -10.8 | -1237.32 | -113.3 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-299.89 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-27.78 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
64924.32 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-49.48 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
16.47 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-368.0 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-41.41 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
-63.97 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-71.74 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
-19.96 | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
-3.23 | $ 32.59 | -6.89 % | $ 877 M | ||
|
Forte Biosciences
FBRX
|
-115.85 | $ 21.59 | -1.86 % | $ 280 M | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-439.8 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-69.03 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-165.18 | - | - | $ 344 M | ||
|
IMV
IMV
|
-79.29 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
-7.08 | $ 92.14 | 1.33 % | $ 22.3 B | ||
|
Grifols, S.A.
GRFS
|
6.19 | $ 7.98 | -1.6 % | $ 5.42 B | ||
|
Autolus Therapeutics plc
AUTL
|
-151.88 | $ 1.7 | 3.03 % | $ 452 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
-17.71 | $ 0.86 | -1.42 % | $ 143 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-123.17 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
23.38 | $ 2.8 | 7.28 % | $ 262 M | ||
|
Anika Therapeutics
ANIK
|
-7.7 | $ 14.88 | -0.93 % | $ 213 M | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
Incyte Corporation
INCY
|
29.32 | $ 97.16 | -0.26 % | $ 19 B | ||
|
Ionis Pharmaceuticals
IONS
|
-43.85 | $ 75.56 | -0.29 % | $ 12.1 B | ||
|
Aeterna Zentaris
AEZS
|
-76.42 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 3.4 | -1.16 % | $ 5.6 M | ||
|
AIkido Pharma
AIKI
|
-80.33 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
-296.87 | $ 1.61 | 2.55 % | $ 189 M | ||
|
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-58.56 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-155.07 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-6.45 | $ 20.86 | -0.71 % | $ 2.65 B | ||
|
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M |